ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Recruiting · NCT07021989 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma | Hemic and Lymphatic Diseases, Hodgkin Lymphoma, Adult, Hodgkins lymphoma, Neoplasms by Histologic Type, classic Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-08-20 | NCT07021989 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Foresight Diagnostics, Inc. | 2 |
| Gateway for Cancer Research | 32 |
| Michael Spinner, MD | 1 |
| Natera, Inc. | 45 |
| UC Hematologic Malignancies Consortium (UCHMC) | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California Davis | Davis | United States | 3 |
| University of California Irvine | Irvine | United States | 5 |
| University of California San Francisco-Fresno | Fresno | United States | 1 |
| University of California, San Diego | La Jolla | United States | 38 |
| University of California, San Francisco | San Francisco | United States | 294 |
| Unversity of California, Los Angeles | Los Angeles | United States | 1 |